Biomarker Analytics · Healthcare Performance Intelligence
Biomarker Analytics Built for Trajectories, Not Isolated Results
Move from red/green lab flags to clinically reviewable trajectories: persistence, rate of change, concordance, context and uncertainty.
See What Vizier Finds in Your DataBring the data you already collect. Keep the systems that produce it.
The buyer problem
More data has made interpretation harder for clinicians, laboratory leaders and health-data teams.
A result can remain inside a population reference interval while moving materially from a person's baseline. Conversely, an isolated outlier may reflect collection conditions, assay changes or ordinary variation.
The answer is not another isolated dashboard. It is a governed way to evaluate change across time and modalities, preserve what each source can and cannot establish, and make the underlying evidence available for review.
Where interpretation breaks
- Units and reference intervals change between labs
- Single values dominate attention
- Related markers are reviewed on different screens
- Intervention timing is mistaken for proof of effect
Data landscape
The signals involved
The job is not to force unlike data into one score. It is to preserve provenance, time, context and uncertainty while making the relationships investigable.
Result history
Values, units, reference intervals, assay and specimen metadata.
Collection context
Fasting status, time, acute illness and other available confounders.
Related signals
Clinically relevant marker groups and phenotype context.
Interventions
Time-bounded medication, supplement and behaviour changes.
The intelligence layer
What Vizier adds
Personal-baseline movement
Identify meaningful change even when a value remains in range.
Persistence analysis
Separate one-off excursions from repeated or accelerating patterns.
Concordance review
Show when related biomarkers support or contradict the same hypothesis.
Data-quality flags
Expose unit, method, missingness and impossible-transition problems before interpretation.
Interpretation discipline
Evidence before certainty
Vizier should make complex data easier to investigate without making the evidence stronger than it is. A temporal relationship is not automatically causal. A genetic association is not a diagnosis. Movement in a surrogate biomarker is not necessarily a clinical outcome.
Findings should retain source, timing, reference context and confidence. Where modalities disagree, data is missing, or follow-up is too short, the useful answer is often that the evidence is insufficient.
The distinctions that matter
- Association is not causality; timing and confounding still matter.
- Genetic predisposition is not the same as expressed phenotype.
- Biomarker movement is not automatically a clinical outcome.
- A biological-age estimate is model output, not a lifespan prediction.
Clear product boundary
What Vizier does—and does not—replace
Vizier analyses validated laboratory outputs. It is not a laboratory information system, reference-range authority or diagnostic engine.
Vizier consumes authorised outputs from the systems you choose. Source access, format, identity matching, governance, hosting and clinical review responsibilities are confirmed during discovery.
Vizier is not
- A sequencing or FASTQ/BAM/VCF processing pipeline
- A laboratory, EHR, scheduling, billing or CRM system
- A diagnostic device or autonomous clinical decision-maker
- A claim that an intervention caused a later change
Workflow
From fragmented outputs to a reviewable investigation
01
Inventory authorised sources, identifiers, time semantics and decision questions.
02
Validate units, mappings, provenance, missingness and clinically relevant comparison periods.
03
Configure longitudinal and cross-signal investigations around the organisation's reviewed definitions.
04
Return findings with evidence, uncertainty and a traceable path back to source data.
Questions buyers ask
Frequently asked questions
What is biomarker analytics?
Biomarker Analytics is the governed analysis of relevant health data for longitudinal and cross-signal questions. For Vizier, that means analysing authorised outputs while retaining provenance, time and uncertainty.
Does Vizier replace our existing clinical or diagnostic systems?
Vizier analyses validated laboratory outputs. It is not a laboratory information system, reference-range authority or diagnostic engine.
Can Vizier prove that an intervention caused a change?
Not from timing alone. Vizier can align observations to an intervention, show competing explanations and describe the strength of evidence. Causal claims require an appropriate design and expert review.
How does implementation start?
With one decision question and a source inventory. Vizier validates access, identifiers, units, time semantics, governance and the review workflow before a capability is represented as production-ready.
See biomarker analytics across the data you already collect.
Bring the data you already collect. See what Vizier finds across it.
Start with the data you already have. Connect your EHR when you’re ready.